Internal Medicine Alert - January 30, 2007

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Allan J. Wilke, MD
Residency Program Director
Associate Professor of Family Medicine
University of Alabama
Birmingham School of Medicine
Huntsville Regional Medical Campus
Huntsville

Eileen C. West, MD
Director
Primary Care Women's Health
Clinical Assistant Professor
Internal Medicine
Obstetrics and Gynecology;
University of Oklahoma Health Sciences Center
Oklahoma City

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Malcolm Robinson, MD, FACP, FACG
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine
Oklahoma City

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Author
Norman R. Relkin, MD, PhD
Associate Professor
Clinical Neurology and Neuroscience
New York Presbyterian Hospital
Cornell Campus

Subjects:

  • Antipsychotics in Alzheimer's Patients: The CATIE-AD Study
  • Dr. Google, I Presume
  • How Much Do Those Nutrients Really Help You?
  • Long-Term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
  • Paliperidone Extended-Release Tablets (Invega™)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD and associate editors Allan J. Wilke, MD, Eileen C. West, MD, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD report no financial relationships to this field of study. Author Norman R. Relkin, MD, PhD is on the speaker's bureau for Pfizer, Eisai, and Athena Diagnostics, and does research for Pfizer and Merck. Associate editor Malcolm Robinson, MD, FACP, FACG serves as a consultant for TAP, Pfizer, Janssen, Eisai, J&J-Merck, and Procter & Gamble, is on the speaker's bureau of Janssen, Eli Lilly, Solvay, TAP, and Aventis, and does research for Forest Labs, Wyeth-Ayerst, AstraZeneca, and Centocor. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2007 AHC Media. All rights reserved.